Kazia had a transformational year in 2019 with initial clinical efficacy read-outs from both its key R&D programs.
The healthcare-focused advisory group boasts good levels of forward bookings thanks to several new business wins at the beginning of 2019
Arecor Limited is a privately-owned biopharmaceuticals company developing superior diabetes care through the application of its innovative formulation technology platform
The Princeton, New Jersey-based women’s health company is offering 15 million shares at a price of $3 each
In May 2019, Maxcyte saw the second cohort of patients begin dosing in a phase I trial using its lead MCY-M11 cancer immunotherapy
The biotechnology company is undergoing regulatory processes in Australia, the US and Europe for its injectable Pentosan Polysulfate Sodium (iPPS) drug.